跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 295,114 条关于
“TTR amyloidosis with cardiomyopathy”
全部
295,114
临床试验
252,279
药物
2,096
机构
415
资讯
40,324
10个月前
Royalty Pharma Acquires $310 Million AMVUTTRA Royalty Interest from Blackstone Life Sciences
去年
FDA Accepts Alnylam's Vutrisiran sNDA for ATTR Amyloidosis with Cardiomyopathy
去年
FDA Accepts Alnylam's Vutrisiran Application for ATTR Amyloidosis with Cardiomyopathy
去年
FDA Grants Fast Track Designation to ALXN2220 for ATTR Amyloidosis with Cardiomyopathy
去年
Alnylam's Nucresiran Shows Sustained TTR Reduction in Phase 1 ATTR Amyloidosis Trial
去年
Alnylam's Nucresiran Shows Sustained TTR Knockdown in Phase 1 ATTR Amyloidosis Trial
去年
Novo Nordisk Advances Coramitug to Phase 3 for ATTR Cardiomyopathy Following Successful Phase 2 Trial
去年
Intellia's CRISPR Therapy Nexiguran Ziclumeran Shows Promise in ATTR Amyloidosis Phase 1 Trial
去年
Intellia's Nexiguran Ziclumeran Shows Promising Phase 1 Results in ATTR Amyloidosis
10个月前
Coramitug Phase 2 Data Published in Circulation as Novo Nordisk Advances Phase 3 CLEOPATTRA Trial for ATTR Cardiomyopathy
第 1 页，共 4033 页
上一页
下一页
